Skip to content

Effect of preoperative oral carbohydrate on insulin resistance and cancer prognosis in patients with type 2 diabetes undergoing selective surgery

Effect of preoperative oral carbohydrate on insulin resistance and cancer prognosis in patients with type 2 diabetes undergoing selective surgery: a randomised controlled clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050804
Enrollment
Unknown
Registered
2021-09-04
Start date
2021-09-06
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Non diabetic group:400ml 12.5% carbohydrates taken orally 2-3 hours before operation
Type 2 diabetes control group:400ml artificial sweetener solution taken orally 2 ~ 3 h before operation
Type 2 diabetes intervention group:400ml 12.5% carbohydrates taken orally 2 ~ 3 h before operation

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patients were diagnosed as type 2 diabetes (preoperative fasting blood glucose control was < 7.1 mmol/l); 2. Colorectal cancer diagnosed by colonoscopy biopsy and CT examination showed that there was no distant metastasis and radical resection could be performed, and no anti colon cancer treatment such as radiotherapy and chemotherapy was performed before operation; 3. Aged 18 to 80 years, male and female, ASA grade II - III; 4. Voluntarily participate in the experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, lung, brain and liver dysfunction; 2. Emergency or palliative surgery; 3. Coexisting diseases leading to impaired gastric emptying (intestinal obstruction, gastroesophageal reflux, esophageal hiatal hernia, history of chronic aspiration); 4. Those who may have difficulty in endotracheal intubation; 5. Those who received parenteral nutrition support before operation; 6. Elevated blood sugar caused by drugs; 7. Patients with unclear mind and consciousness after operation; 8. The operation time was longer than 6-8 h. Due to the problem of drug accumulation, the postoperative water intake time was appropriately prolonged; 9. Allergic to fructose or malt paste; 10. Those with communication or cognitive impairment, alcohol dependence and history of drug abuse; 11. Lactating and pregnant women.

Design outcomes

Primary

MeasureTime frame
Perioperative insulin resistance;

Secondary

MeasureTime frame
Perioperative blood glucose;Cancer prognosis;Gastric emptying 1 hour before operation;Perioperative patient comfort;Perioperative complications;The length of hospital stay;

Countries

China

Contacts

Public ContactLyu Feng

The First Affiliated Hospital of Chongqing Medical University

lvfengmazui@sina.cn+86 18523875597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026